Trial intelligence / Profile preview

Comparative Study of Anthelmintic Drugs for Clonorchiasis

ChiCTR2500115406Phase 4Recruiting

Sponsor
Guangxi Zhuang Autonomous Region People's Hospital
Start
Dec 2025
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised trial in clonorchiasis comparing Tribendimidine arm, Albendazole arm and Praziquantel arm (3 arms). Primary endpoint: Fecal egg examination and egg reduction rate for Clonorchis sinensis. Started Dec 2025; status: recruiting.

02

Drugs

albendazolepraziquanteltribendimidine
03

Conditions

clonorchiasis

Beyond the preview

Go deeper on ChiCTR2500115406.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR2500115406.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call